-transparent.png){kind=logo}
A series of 4-phenyl-2-thioxo-benzo[4,5]thieno[2,3-d]pyrimidine derivatives endowed with anti-inflammatory and related pharmacological properties were submitted to a more extensive study to know their exact pharmacological profile and their possible side effects. The studied compounds possess a remarkable analgesic activity, devoid of central effects. They also show an interesting anti-inflammatory profile evidenced by their effectiveness in different experimental models of inflammation. In addition, these compounds exhibit none or very little activity on CNS, scarce toxicity and low gastrointestinal aggressivity.
Related Publications
V Darias, and
S S Abdallah, and
M L Tello, and
L D Delgado, and
S Vega
December 1999,
Arzneimittel-Forschung,
V Darias, and
S S Abdallah, and
M L Tello, and
L D Delgado, and
S Vega
January 2020,
Archiv der Pharmazie,
V Darias, and
S S Abdallah, and
M L Tello, and
L D Delgado, and
S Vega
January 2012,
Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society,
V Darias, and
S S Abdallah, and
M L Tello, and
L D Delgado, and
S Vega
December 2022,
Iranian journal of pharmaceutical research : IJPR,
V Darias, and
S S Abdallah, and
M L Tello, and
L D Delgado, and
S Vega
March 2017,
Bioorganic & medicinal chemistry letters,
V Darias, and
S S Abdallah, and
M L Tello, and
L D Delgado, and
S Vega
September 2019,
Bioorganic chemistry,
V Darias, and
S S Abdallah, and
M L Tello, and
L D Delgado, and
S Vega
November 2017,
Molecules (Basel, Switzerland),
V Darias, and
S S Abdallah, and
M L Tello, and
L D Delgado, and
S Vega
July 2013,
European journal of medicinal chemistry,
V Darias, and
S S Abdallah, and
M L Tello, and
L D Delgado, and
S Vega
November 2017,
Chemistry Central journal,
V Darias, and
S S Abdallah, and
M L Tello, and
L D Delgado, and
S Vega
January 2000,
Die Pharmazie,
